BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38061978)

  • 21. Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study.
    Oing C; Oechsle K; Necchi A; Loriot Y; De Giorgi U; Fléchon A; Daugaard G; Fedyanin M; Faré E; Bokemeyer C
    Ann Oncol; 2017 Mar; 28(3):576-582. PubMed ID: 27993806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases.
    Guo CC; Punar M; Contreras AL; Tu SM; Pisters L; Tamboli P; Czerniak B
    Am J Surg Pathol; 2009 Aug; 33(8):1173-8. PubMed ID: 19561445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
    Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
    World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.
    Adra N; Althouse SK; Liu H; Brames MJ; Hanna NH; Einhorn LH; Albany C
    Ann Oncol; 2016 May; 27(5):875-9. PubMed ID: 26861605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment.
    Fankhauser CD; Gerke TA; Roth L; Sander S; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Beyer J; Hermanns T
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):781-785. PubMed ID: 30637464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncologic outcomes of pre-malignant and invasive germ cell tumors in patients with differences in sex development - A systematic review.
    Morin J; Peard L; Vanadurongvan T; Walker J; Dönmez Mİ; Saltzman AF
    J Pediatr Urol; 2020 Oct; 16(5):576-582. PubMed ID: 32564942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
    Chanal E; Bouleftour W; Guillot A; Rowinski E; Bernichon E; Tremeau L; Lardon R; Lacroix B; Lorin S; Delorme G; Perraud Y; Armand C; Levigne F; Vallard A; Langrand-Escure J; Fournel P; Benoite M; Vassal C
    Bull Cancer; 2019 Dec; 106(12):1086-1093. PubMed ID: 31582176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.
    Gittleman H; Cioffi G; Vecchione-Koval T; Ostrom QT; Kruchko C; Osorio DS; Finlay JL; Barnholtz-Sloan JS
    J Neurooncol; 2019 Jun; 143(2):251-260. PubMed ID: 31025275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
    Balzer BL; Ulbright TM
    Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.
    Miller RE; Markt SC; O'Donnell E; Bernard B; Albiges LK; Beard C; Sweeney CJ
    Eur Urol Focus; 2017 Dec; 3(6):621-628. PubMed ID: 28753801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic type, staging, and distribution of germ cell tumors in Korean adults.
    Park DS; Chung MK; Chung JI; Ahn HJ; Lee ES; Choi HY; Yoon DK; Cheon J; Hong SJ; Lee YG; Yoon SM; Kim WJ; Kim HJ; Ryu SB; Ro JY
    Urol Oncol; 2008; 26(6):590-4. PubMed ID: 18367106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic findings and clinical outcomes in patients who required neoadjuvant chemotherapy before orchiectomy for testicular germ cell tumors.
    Stump JA; Acosta AM; Whaley RD; Cheng L; Fang AM; Rais-Bahrami S; Gordetsky JB
    Hum Pathol; 2022 Oct; 128():48-55. PubMed ID: 35817140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.
    Adra N; Einhorn LH; Althouse SK; Ammakkanavar NR; Musapatika D; Albany C; Vaughn D; Hanna NH
    Ann Oncol; 2018 Jan; 29(1):209-214. PubMed ID: 29045540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
    Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
    J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.
    Fizazi K; Gravis G; Flechon A; Geoffrois L; Chevreau C; Laguerre B; Delva R; Eymard JC; Rolland F; Houede N; Laplanche A; Burcoveanu D; Culine S
    Ann Oncol; 2014 May; 25(5):987-91. PubMed ID: 24595454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy.
    Caso R; Jones GD; Tan KS; Bosl GJ; Funt SA; Sheinfeld J; Reuter VE; Amar D; Fischer G; Molena D; Rocco G; Bains MS; Feldman DR; Jones DR
    Ann Thorac Surg; 2021 Apr; 111(4):1141-1149. PubMed ID: 32882201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages.
    Kliesch S; Schmidt S; Wilborn D; Aigner C; Albrecht W; Bedke J; Beintker M; Beyersdorff D; Bokemeyer C; Busch J; Classen J; de Wit M; Dieckmann KP; Diemer T; Dieing A; Gockel M; Göckel-Beining B; Hakenberg OW; Heidenreich A; Heinzelbecker J; Herkommer K; Hermanns T; Kaufmann S; Kornmann M; Kotzerke J; Krege S; Kristiansen G; Lorch A; Müller AC; Oechsle K; Ohloff T; Oing C; Otto U; Pfister D; Pichler R; Recken H; Rick O; Rudolph Y; Ruf C; Schirren J; Schmelz H; Schmidberger H; Schrader M; Schweyer S; Seeling S; Souchon R; Winter C; Wittekind C; Zengerling F; Zermann DH; Zillmann R; Albers P
    Urol Int; 2021; 105(3-4):169-180. PubMed ID: 33412555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
    Richardson NH; Althouse SK; Ashkar R; Cary C; Masterson T; Foster RS; Einhorn LH; Adra N
    Clin Genitourin Cancer; 2023 Aug; 21(4):467-474. PubMed ID: 37088659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.